Overview of Tisseel-Lyo
Tisseel-Lyo: Quick Facts and Foundational Identity
Tisseel-Lyo is a specialized biological product defined by its core active components, Human Fibrinogen and Human Thrombin, supplied as a Lyophilized Powder within a kit for topical application. It is classified as a Topical Hemostatic Agent, also known as a Fibrin Sealant, and its primary function is to assist in Hemostasis and Biological Sealing.
What is Tisseel-Lyo and What Type of Agent is it?
Tisseel-Lyo is classified as a combination biological product and a Topical Hemostatic Agent, fundamentally used to support bleeding control and tissue closure in surgical procedures. It belongs to the class of Fibrin Sealants, acting as a rapid tissue adhesive. This medicine is designed to rapidly achieve a stable clot in situations where conventional methods may be inadequate. The product is derived from Human Plasma donations, a key attribute that dictates its components, Fibrinogen and Thrombin, are purified, naturally occurring proteins. The specific inclusion of the stabilizer Aprotinin and the delivery method distinguishes the Tisseel formulation as a widely recognized option within its class for its reliability in establishing clot integrity.
Composition and the Role of Lyophilized Components
The unique presentation of Tisseel-Lyo is supplied as a Kit for Solution for Sealant, distinguished by the components being in a Lyophilized Powder state before reconstitution for topical use. This specialized, freeze-dried form is essential for preserving the maximum stability and biological activity of the protein components, Human Fibrinogen and Human Thrombin, until the point of preparation. The kit also integrates crucial excipients, including Calcium Chloride (CaCl2), which is required to fully activate the Thrombin enzyme, and Aprotinin, a synthetic inhibitor that increases the stability and longevity of the newly formed Fibrin clot, which supports clot resistance to premature enzymatic breakdown.
General Purpose: Hemostasis and Biological Sealing
The general purpose of this product is to rapidly establish localized clotting and provide immediate mechanical support for Biological Sealing. By directly supplying and combining Fibrinogen and Thrombin, the product effectively and predictably bypasses the preceding steps of the natural Coagulation Cascade. This localized enzymatic action rapidly converts the Fibrinogen into a stable, adhesive Fibrin matrix that aids in achieving effective Hemostasis and supports the approximation of tissue surfaces in a typical use scenario like reinforcing an anastomosis or sealing large tissue surfaces after surgical dissection.

